IL2 and systemic lupus erythematosus: Similarly, lupus mice treated with IL-2-loaded NPs targeted to Tfh cells showed decreased number of Tfh cells, low serum levels of IgG1 and IgG2a, downregulated proteinuria, and extended survival (159).